The neuron-like differentiation of PC12 cells is induced by nerve growth factor (NGF) through stimulation of a membrane-bound protooncoprotein signaling pathway containing the NGF receptor Trk, the tyrosine kinase Src, and the GTP-binding protein Ras. The Raf-1 and B-raf protooncogenes encode cytoplasmic serine/threonine kinases that are stimulated by NGF in a Ras-dependent manner. To investigate the possible roles of cytoplasmic Raf kinases in eliciting neuronal differentiation, we have expressed the activated Raf-l oncogene in PC12 cells. Expression of the rafoncogene results in the elaboration of a neuron-like phenotype, including neurite growth and the induction of the NGF-responsive genes NGFI-A and transin. The actions of activated Raf-l and NGF are not additive. Furthermore, activated Raf-1 oncoprotein can prime cells for transcription-independent neurite growth by NGF and can elicit rapid neurite growth from NGF-primed cells. Our data indicate that the pathways utilized by NGF and activated raf to effect PC12 differentiation overlap and lead to the suggestion that cellular raf kinase activities play significant roles in transducing the differentiating signals of neuronal growth factors.
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The rat pheochromocytoma cell line PC12 has served as a model system for examining the mechanism of action of neuronal growth factors (1, 2). When treated with nerve growth factor (NGF) or fibroblast growth factor (FGF) these cells acquire a phenotype resembling sympathetic neurons, including the extension of neurites, cessation of cell division, acquisition of a Na+-based action potential, and expression of genes encoding specific neuronal markers (2). NGF and FGF each act through transmembrane receptor protein tyrosine kinases (3-5) and subsequently stimulate multiple serine/threonine kinase activities (2). However, the cascade of events responsible for the differentiating activity of these neuronal growth factors remains to be fully elucidated.
NGF actions can be mimicked by expression of the activated viral src or viral ras oncogenes in PC12 cells (6) (7) (8) . The functions of the cellular Ras and Src protooncoproteins are necessary for neuronal growth factor-stimulated differentiation (9) (10) (11) , suggesting that the signaling pathways leading to mitogenesis and to neuronal differentiation overlap. However, in contrast to the actions of NGF and FGF, ligand activation of the epidermal growth factor (EGF) or insulin receptor tyrosine kinases, or expression of the activated tyrosine kinase product of the erbB oncogene, encoding a truncated EGF receptor, stimulates mitogenesis rather than differentiation of PC12 cells (ref. 1; S. M. Thomas, B. E. Meyer, S.H., and J. S. Brugge, unpublished data). The distinct actions of these receptor tyrosine kinases indicate a
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. divergence of the signaling pathways leading to mitogenesis from those leading to neuronal differentiation in PC12 cells. This divergence is also indicated by the actions of cytoplasmic and nuclear oncoproteins, including BCR-abl (S. M. Thomas, B. E. Meyer, S.H., and J. S. Brugge, unpublished data), fos (12) , myc and adenovirus ElA (13) , all of which fail to induce PC12 differentiation. Furthermore, expression offos, myc, or ElA blocks the differentiating actions of NGF (12, 13) . Thus, it appears that within the many growth factor-stimulated signaling pathways, there are unique, mutually antagonistic elements contributing either to mitogenesis or to differentiation.
The Raf-1 and B-raf protooncogenes encode cytoplasmic serine/threonine kinases. Raf-1 has been implicated in tyrosine kinase-dependent signaling pathways that underlie cell growth and transformation (14, 15) . In PC12 cells, ligand activation of the NGF (16) (17) (18) (19) (20) or EGF (16) receptor tyrosine kinases leads to rapid hyperphosphorylation of both Raf kinases and activation of their respective associated kinase activities in a Ras-dependent manner. To address the potential roles of Raf kinases in mediating neuronal growth factor actions, we have examined the effects of expressing in PC12 cells oncogenically activated Raf-1.
MATERIALS AND METHODS
Cell Culture and Antisera. PC12 cells (21) and f-2 cells (22) were cultured as described (16, 22) . Anti-Raf-1 C-terminal peptide antiserum was raised and affinity purified as described (23) .
Neurite Counting. For priming, IC4-rafcells (104 cells per 35-mm dish) were treated with 100 ng of NGF per ml for 3 days or with 0.5 ,uM dexamethasone (i.e., activated Raf-1) for 5 days and then passed onto poly(L-lysine)-coated dishes and allowed to adhere (=6 hr). Dexamethasone (0.5 A&M) or NGF (100 ng/ml) was added to the appropriate dishes and neurites longer than two cell body diameters were scored at times thereafter. NGF-induced regeneration of neurites from IC4-rafcells primed with dexamethasone or NGF for 5 days was also carried out in the presence of 0.5 ,uM sodium camptothecin to block transcription (24) . Background levels of neurite regeneration were determined using primed cells plated in the presence of camptothecin but in the absence of NGF and were subtracted from the experimental values.
Construction of Vectors. Retrovirus vectors were constructed in pLNCX (25) . pLNcraf contains the entire coding sequence of human c-raf-1 cDNA. pLN42K contains a human c-raf-1 cDNA oncogenically activated by deletion of codons 3-333 (26) . pMM42K contains the activated c-raf-1 Abbreviations: NGF, nerve growth factor; FGF, fibroblast growth factor; MMTV, mouse mammary tumor virus; EGF, epidermal growth factor. §To whom reprint requests should be addressed.
cDNA cloned downstream of the mouse mammary tumor virus (MMTV) long terminal repeat of pMMJE (kindly provided by Barrett Rollins, Dana-Farber Cancer Institute, Boston) from which the JE cDNA had been excised.
Construction of Retrovirus-Producing Cell Lines. Clonal, stably infected, virus-producing f-2 cell lines were constructed by infection with retrovirus produced by pools of /-2 cells stably transfected with pLNCX, pLNcraf, or pLN42K by the calcium phosphate method. Infected cells were selected with 0.4 mg of G418 per ml. Supernatants from clones producing the highest titer virus (all >105 per ml) were collected, filtered through 0.45-gm filters, and frozen in liquid N2.
Retrovirus Infection of PC12 Cells. PC12 cells cultured on poly(L-lysine)-coated 60-mm dishes at day 3 of passage were infected with viral supernatant containing 8 ,ug of polybrene per ml. After 4-6 hr, an equal volume of normal culture medium was added, the cells were incubated overnight, and the medium was changed the following day. G418 was added at 0.8 mg/ml the following day.
Construction of PC12 Cell Lines Inducibly Expressing Truncated Raf-1. PC12 cells were cotransfected with pMM42K and pRSVneo using Lipofectin reagent (BRL) (27) or by electroporation (10) . G418-resistant clones were screened for dexamethasone-inducible neurites.
Northern Blotting. Total cellular RNA was isolated, subjected to formaldehyde gel electrophoresis, and transferred to nylon membranes. Blots were hybridized to either [a-32P]-UTP-labeled antisense RNA probes or to [a-32P]dCTP-labeled random primed probe as described (28) .
Immunoblotting. Anti-Raf-1 immunoblotting was performed essentially as described (29) , probing with affinitypurified antibody. For quantitative analysis immunoblots were digitally scanned using a Hewlett-Packard ScanJet Plus and quantitated using Biosoft scan analysis (Biosoft, Milltown, NJ) on a Macintosh IIfx. All quantitative measurements fell within the linear range of detection.
RESULTS
Activated Raf-1 Induces Neurite Outgrowth. We constructed retroviral vectors carrying cDNAs encoding either full-length Raf-1 or an N-terminally truncated, oncogenically activated Raf-1 and asked if infection with either of these viruses induced neurite extension, the most prominent marker of PC12 differentiation. As shown in Fig. 1 (Fig. 1A) . In contrast, -10% of cells infected with virus bearing the activated raf oncogene extended neurites with prominent growth cones (Fig. 1C) . Anti-Raf-1 immunoblots of whole cell extracts prepared from populations of cells infected with these viruses confirmed expression of the virally encoded proteins (Fig. 1D) . After passage the proportion of neuritebearing cells in these cultures diminished rapidly, suggesting that the population of neurite-bearing cells had ceased dividing and could thus not be propagated (data not shown). As shown in Fig. 1D , the activated rafoncogene gave rise to two proteins of approximately 37 kDa and 39 kDa recognized by antibody directed against the C terminus of Raf-1. These two proteins may be phosphorylated isoforms of truncated Raf-1 or may reflect limited N-terminal proteolysis.
To facilitate characterization of activated Raf-l-induced PC12 differentiation we constructed clonal PC12 cell lines carrying the activated raf oncogene under the control of the dexamethasone-inducible MMTV long terminal repeat. Three clones were isolated that displayed neurites to varying extents when cultured in the presence of dexamethasone. In each case, dexamethasone treatment also induced the ex- (Fig. 3B) . This time course is significantly longer than that for NGF-, v-src-, or activated ras-induced neurite growth in PC12 cells (8, 30, 31) or for NGF-induced neurite growth in IC4-raf cells (Fig. 3B) . The long time required for raf-directed neurite growth is not due to delayed expression of truncated Raf-1, which is detectable following as little as 2 hr of dexamethasone treatment and which peaks at 6-8 hr (Fig. 2D) , persisting for at least 5 days.
As with NGF-induced and v-src-or activated ras-induced neurite extension, the extension of neurites stimulated by the expression of activated rafwas reversible. Removal of dexamethasone from the culture medium of IC4-rafcells cultured for 9 days in the presence ofdexamethasone results in the loss of neurites within 7 days, as shown in Fig. 2 B and C.
Priming of Neurite Outgrowth by NGF or Activated Raf-1. If activated rafand NGF stimulate neurite extension through nonoverlapping pathways, then the effects of NGF and expression of activated rafmight be expected to be additive. As shown in Fig. 3B , simultaneous treatment of IC4-rafcells with NGF and dexamethasone did not elicit a response greater than that observed in response to NGF alone, suggesting that the pathways utilized by activated Raf-1 and NGF to stimulate neurite extension are overlapping. To investigate this possibility further we examined the abilities of activated Raf-1 to prime for NGF-stimulated neurite outgrowth and for NGF to prime for Raf-l-induced neurite extension.
During the first 48 hr of NGF treatment, transcriptiondependent events are elicited that can prime PC12 cells to respond precociously to subsequent NGF treatment after replating. After cells are primed with NGF, neurite regeneration requires only post-transcriptional processes and occurs without the characteristic 48-hr lag time (32) . The long lag time for neurite outgrowth following induction of activated raf expression suggests that activated Raf-1-induced neurite outgrowth may also be dependent upon activated Raf-1-induced transcriptional events. Since induction of activated Raf-1 in IC4-raf cells is itself transcription dependent, this suggestion cannot be tested in IC4-rafcells using inhibitors of transcription. However, we have tested for the ability of activated Raf-1 to prime cells for neurite regeneration by NGF. Toward this end, IC4-raf cells were treated with dexamethasone for 5 days and replated in the growth medium lacking dexamethasone, in the presence or absence of NGF. Control IC4-raf cultures, not treated previously with dexamethasone, were also plated in the presence or absence of NGF. Neurite growth was followed over the next 7 days after replating. The results, shown in Fig. 4A , show that NGFinduced neurite outgrowth from IC4-raf cells has a significantly shorter lag time than has been observed previously for PC12 cells (1). However, pretreatment of IC4-raf cells with dexamethasone still caused a >2-fold increase in the rate of NGF-stimulated neurite regeneration within the first 24 hr after replating, relative to unprimed IC4-raf cells. As expected, the priming effect of activated Raf-1 disappeared gradually over the next several days (Fig. 4A) . To ensure that the NGF-induced regeneration of neurites in raf-primed cells was transcription independent, the RNA synthesis inhibitor camptothecin was used. NGF-induced neurite regeneration from dexamethasone-primed IC4-raf cells was examined as above but in the presence of 0.5 ,uM sodium camptothecin. This concentration of camptothecin, which partially blocks RNA synthesis, completely blocks NGF-induced neurite outgrowth in unprimed IC4-rafcells, as in PC12 cells (ref. 24 ; data not shown). After dexamethasone-induced priming of IC4-raf cells, NGF was able to induce transcriptionindependent neurite regeneration in 35% ± 1% of the cells within 36 hr. This is smaller than, but comparable to, the level of NGF-induced neurite regeneration obtained in the presence of camptothecin from cells primed with NGF for 5 days (46% ± 2% of NGF-primed cells regenerated neurites). The background levels of neurite regeneration for raf-and NGFprimed cells replated in the absence of NGF and the presence ofcamptothecin were 3% and 9o, respectively. These results suggest that expression of activated Raf-1 is able to mimic the transcription-dependent priming of NGF.
To determine if expression of activated Raf-1 can mimic post-transcriptional actions of NGF, we examined the ability of activated Raf-1 to induce rapid neurite regeneration from NGF-primed IC4-raf cells. As mentioned above, neurite regeneration stimulated by NGF is mediated through posttranscriptional events. As shown in Fig. 4B treatment of NGF-primed IC4-raf cells with dexamethasone for 1 day resulted in dramatic neurite growth (in >30%o of the cells) as compared with neurite growth seen in unprimed IC4-raf cells inn. treated with dexamethasone (in <5% of the cells). These data suggest that activated Raf-1, like NGF, may support rapid neurite regeneration through post-transcriptional mechanisms. One day after replating, the level of neurite regeneration elicited by activated Raf-1 in NGF-primed cells (Fig.  4B ) is similar to that resulting from NGF treatment of Raf-1-primed IC4-raf cells (Fig. 4A ), though at later times NGF is able to elicit more substantial neurite outgrowth. Unlike the priming effect of raf on NGF-induced neurite regeneration, the priming effect of NGF on raf-induced neurites was long lasting and was still apparent after 7 days of continuous dexamethasone treatment (Fig. 4B) . NGF priming also allowed for a much more extensive neurite outgrowth during long-term activated Raf-1 expression than with unprimed cells. This was seen not only in the number of cells displaying neurites (Fig. 4B) but also in the extensive network of neurites elaborated (data not shown), which was normally seen only with long-term NGF treatment. raf Activation of Primary and Secondary Response Genes. NGF treatment of PC12 cells results in the expression of sets of genes according to a temporal pattern of induction (2). We have examined the effect of activated raf expression on the pattern of expression of representative members of primary and secondary response genes in IC4-raf cells. The primary response gene NGFI-A (33) was induced in IC4-raf cells following dexamethasone induction of activated Raf-1 expression (Fig. 5A) . Expression ofNGFI-A was elicited within 4 hr of dexamethasone treatment, reaching a maximal induction by 8 hr. Although the transient accumulation of mRNAs for primary response genes such as NGFI-A is normally initiated within 15 min of NGF treatment (33) , the induction of NGFI-A in response to dexamethasone treatment parallels the peak in expression of truncated Raf-1 mRNA and protein (Figs. 2D and SA) . However, the level of induction of NGFI-A by activated Raf-1 is significantly less than that induced by NGF (Fig. SA) . This may be due at least in part to the long time required for dexamethasone-induced accumulation of activated Raf-1 relative to The secondary response gene transin is induced by NGF in PC12 cells within 1 day of treatment (35) . The transin gene was also induced following dexamethasone treatment of IC4-rafcells. Transin mRNA, as seen by Northern analysis, begins to accumulate within 8 hr following dexamethasone treatment, with a maximal induction occurring at -4 days of treatment (Fig. 5B) . This time course is notably longer than that seen in response to NGF treatment. However, the magnitude of transin induction is even greater than that seen in response to NGF treatment of PC12 cells or IC4-raf cells. Dexamethasone treatment of PC12 cells does not result in any increase in transin mRNA levels, though it does attenuate transin induction by NGF (ref. 3-5; data not shown).
DISCUSSION
Our results demonstrate that expression of the activated raf oncogene in PC12 cells can induce the initiation and elongation of neuritic processes and increase the expression of the primary response gene NGFI-A and the secondary response gene transin. As with NGF-and FGF-induced differentiation, activated raf-induced neurite extension is reversible. The ability of activated Raf-1 to prime PC12 cells for subsequent transcription-independent NGF-induced neurite regeneration and to support the regeneration of neurites from NGFprimed PC12 cells suggests that NGF and activated Raf-1 share critical effectors in the transcription-dependent and transcription-independent pathways that stimulate and support neurite outgrowth. This is supported by the observation that NGF and activated raf are not additive in their ability to induce neurite growth.
Our results suggest that neuronal growth factors activate a serine/threonine kinase activity with a substrate specificity similar to that of oncogenically activated Raf-1. Obvious candidates for this kinase activity are the cellular kinases Raf-1 and B-raf. In view of the homology between the kinase domains of B-raf and Raf-1 (36), it is possible that oncogenically activated Raf-1 may be mimicking the normal actions of either B-raf, Raf-1, or both. The results presented here suggest that cellular raf kinases may be principal mediators of major neuronal growth factor actions leading to differentiation. Expression of dominant inhibitory mutants of Raf-1 and B-raf may further help to address this possibility.
The ability of oncogenic forms of cellular signal transducing molecules to mimic the actions of NGF on PC12 cells emphasizes the extensive overlap in the pathways leading to mitogenesis and to neuronal differentiation. This has been best exemplified by the membrane components of the NGF signal transduction cascade involving the trk, src, and ras protooncogene products, which we have previously shown to function sequentially in NGF-stimulated neurite outgrowth (10). However, not all mediators of mitogenesis mimic NGF action, as is illustrated by the NGF-antagonizing effects of nuclear oncogenes (12, 13) . The ability of the rafoncogene to mimic many of the actions of NGF, including changes in gene expression, indicates that a pathway common to mitogenesis and neuronal differentiation extends from the plasma membrane into the cytoplasm. In the cascade of events leading to neuronal differentiation, members of the raffamily of kinases likely function downstream of the Src and Ras proteins and may provide a link to changes in gene expression.
Although hyperphosphorylation and activation of Raf-1 and/or B-raf may be suggested to mediate neuronal growth factor action in PC12 cells, EGF will also induce hyperphosphorylation of Raf-1 in PC12 cells (16) . The apparent paradox that EGF, which is a mitogen, activates Ras and may activate Raf proteins and yet not induce the neuron-like differentiation of PC12 cells has been previously discussed (37) (38) . Likewise, NGF-induced hyperphosphorylation of Raf-1 in PC12 cells persists for considerably longer than has been observed following mitogen stimulation of other cell types (K.W.W., unpublished observations). However, the inability of the product of the erbB oncogene, encoding a constitutively active mutant of the EGF receptor, to induce PC12 differentiation suggests that persistence ofreceptor activity is probably not the sole determinant of differentiating activity. Expression of activated Raf-1 does not mimic all actions of NGF. The neurites generated upon expression of oncogenically activated Raf-1 are induced more slowly and are not as extensive as those produced in response to NGF. Changes in gene expression are also induced more slowly. These effects cannot be explained solely by the slow time course of the MMTV-raf gene induction by dexamethasone, since induction of MMTV-ras in PC12 cells follows a similar time course, but results in more rapid and extensive neurite growth and gene inductions (10, 28, 31) . Furthermore, the deficiencies of activated Raf-1-induced neurite outgrowth can be overcome by NGF priming, and cells primed with activated Raf-1 do not regenerate neurites as effectively as NGF-primed cells. These results may be taken as evidence for NGF actions that are carried out independently of activated Raf-1 and that complement the differentiating activity of activated Raf-1.
In summary, our results suggest that one or more protein serine/threonine kinases of the raf family mediate neuronal growth factor signal transduction events important for neuronal differentiation. Future studies on the mechanism of Raf-1 and B-rafactivation and on the specific substrates of raf kinases should yield further insights into the mechanism of neuronal growth factor signal transduction.
